Chemoinformaics analysis of (1S,3R,5S)-6,6-DIMETHYL-2-METHYLIDENEBICYCLO[3.1.1]HEPTAN-3-OL
Molecular Weight | 152.237 | nRot | 0 |
Heavy Atom Molecular Weight | 136.109 | nRig | 24 |
Exact Molecular Weight | 152.12 | nRing | 3 |
Solubility: LogS | -3.932 | nHRing | 0 |
Solubility: LogP | 0.245 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.1707 |
nHD | 1 | BPOL | 16.0513 |
QED | 0.238 |
Synth | 3.958 |
Natural Product Likeliness | 1.967 |
NR-PPAR-gamma | 0.941 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.009 |
Pgp-sub | 0.883 |
HIA | 0.789 |
CACO-2 | -6.131 |
MDCK | 0.0000178 |
BBB | 0.073 |
PPB | 0.841187 |
VDSS | 0.936 |
FU | 0.146274 |
CYP1A2-inh | 0.061 |
CYP1A2-sub | 0.073 |
CYP2c19-inh | 0.014 |
CYP2c19-sub | 0.058 |
CYP2c9-inh | 0.014 |
CYP2c9-sub | 0.361 |
CYP2d6-inh | 0.06 |
CYP2d6-sub | 0.212 |
CYP3a4-inh | 0.051 |
CYP3a4-sub | 0.02 |
CL | 5.965 |
T12 | 0.793 |
hERG | 0.012 |
Ames | 0.817 |
ROA | 0.065 |
SkinSen | 0.083 |
Carcinogencity | 0.042 |
EI | 0.027 |
Respiratory | 0.028 |
NR-Aromatase | 0.881 |
Antiviral | No |
Prediction | 0.937852 |